Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD von de With, Mirjam, van Doorn, Leni, Maasland, Demi C., Mulder, Tessa A.M., Oomen-de Hoop, Esther, Mostert, Bianca, Homs, Marjolein Y.V., El Bouazzaoui, Samira, Mathijssen, Ron H.J., van Schaik, Ron H.N., Bins, Sander

Volltext

The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer von Belderbos, Bodine P. S., de With, Mirjam, Singh, Rajbir K., Agema, Bram C., El Bouazzaoui, Samira, Oomen-de Hoop, Esther, de Wit, Ronald, van Schaik, Ron H. N., Mathijssen, Ron H. J., Bins, Sander

Volltext

Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma von Goey, Andrew Kl, With, Mirjam de, Agema, Bram C, Hoop, Esther Oomen-De, Singh, Rajbir K, van der Veldt, Astrid Am, Mathijssen, Ron Hj, van Schaik, Ron Hn, Bins, Sander

Volltext

CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation? von Mulder, Tessa A. M., van Eerden, Ruben A. G., de With, Mirjam, Elens, Laure, Hesselink, Dennis A., Matic, Maja, Bins, Sander, Mathijssen, Ron H. J., van Schaik, Ron H. N.

Volltext

Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients von Agema, Bram C., Koolen, Stijn L. W., de With, Mirjam, van Doorn, Nadia, Heersche, Niels, Oomen-de Hoop, Esther, Visser, Sabine, Aerts, Joachim G. J., Bins, Sander, van Schaik, Ron H. N., Mathijssen, Ron H. J.

Volltext

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study von With, Mirjam, Knikman, Jonathan, Man, Femke M., Lunenburg, Carin A. T. C., Henricks, Linda M., Kuilenburg, André B. P., Maring, Jan G., Staveren, Maurice C., Vries, Niels, Rosing, Hilde, Beijnen, Jos H., Pluim, Dick, Modak, Anil, Imholz, Alex L. T., Schaik, Ron H. N., Schellens, Jan H. M., Gelderblom, Hans, Cats, Annemieke, Guchelaar, Henk‐Jan, Mathijssen, Ron H. J., Swen, Jesse J., Meulendijks, Didier

Volltext

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients von Hulshof, Emma C., de With, Mirjam, Creemers, Geert-Jan, Guchelaar, Henk-Jan, Mathijssen, Ron HJ, Gelderblom, Hans, Deenen, Maarten J.

Volltext

Response to “Plasma Uracil as a DPD Phenotyping Test: Pre‐analytical Handling Matters” von With, Mirjam, Knikman, Jonathan, Schellens, Jan H. M., Gelderblom, Hans, Cats, Annemieke, Guchelaar, Henk‐Jan, Mathijssen, Ron H. J., Swen, Jesse J., Meulendijks, Didier

Volltext

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1 von de With, Mirjam, van Doorn, Leni, Kloet, Esmay, van Veggel, Anne, Matic, Maja, de Neijs, Micha J., Oomen - de Hoop, Esther, van Meerten, Esther, van Schaik, Ron H. N., Mathijssen, Ron H. J., Bins, Sander

Volltext

Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated wi... von Hulshof, Emma C., de With, Mirjam, Creemers, Geert-Jan, Guchelaar, Henk-Jan, Mathijssen, Ron HJ, Gelderblom, Hans, Deenen, Maarten J.

Volltext

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients von Hulshof, Emma C., de With, Mirjam, de Man, Femke M., Creemers, Geert-Jan, Deiman, Birgit A.L.M., Swen, Jesse J., Houterman, Saskia, Koolen, Stijn L.W., Bins, Sander, Thijs, Anna M.J., Laven, Marjan M.J., Hövels, Anke M., Luelmo, Saskia A.C., Houtsma, Danny, Shulman, Katerina, McLeod, Howard L., van Schaik, Ron H.N., Guchelaar, Henk-Jan, Mathijssen, Ron H.J., Gelderblom, Hans, Deenen, Maarten J.

Volltext

CYP3A422 Genotyping in Clinical Practice: Ready for Implementation? von Mulder, Tessa A. M., van Eerden, Ruben A. G., de With, Mirjam, Elens, Laure, Hesselink, Dennis A., Matic, Maja, Bins, Sander, Mathijssen, Ron H. J., van Schaik, Ron H. N.

Volltext

Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study von Man, Femke M., Hussaarts, Koen G.A.M., With, Mirjam, Oomen‐de Hoop, Esther, Bruijn, Peter, Halteren, Henk K., Burg‐de Graauw, Nicole C.H.P., Eskens, Ferry A.L.M., Gelder, Teun, Leeuwen, Roelof W.F., Mathijssen, Ron H.J.

Volltext

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy von Mulder, Tessa A. M., de With, Miriam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.

Volltext

Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer von Heersche, Niels, Veerman, G.D. Marijn, de With, Mirjam, Bins, Sander, Assaraf, Yehuda G., Dingemans, Anne-Marie C., van Schaik, Ron H.N., Mathijssen, Ron H.J., Jansman, Frank G.A.

Volltext

Safety and pharmacokinetic analysis of UGT1A1 genotype-guided dosing of irinotecan von Hulshof, Emma C., de With, Mirjam, de Man, Femke M., Creemers, Geert-Jan, Deiman, Birgit ALM, Swen, Jesse J., Houterman, Saskia, Koolen, Stijn L.W., Laven, Marjan, Luelmo, Saskia, van Schaik, Ron H.N., Guchelaar, Henk-jan, Mathijssen, Ron H.J., Gelderblom, Hans, Deenen, Maarten J.

Volltext

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy von de With, Mirjam, Hurkmans, Daan P., Oomen-de Hoop, Esther, Lalouti, Ayoub, Bins, Sander, El Bouazzaoui, Samira, van Brakel, Mandy, Debets, Reno, Aerts, Joachim G. J. V., van Schaik, Ron H. N., Mathijssen, Ron H. J., van der Veldt, Astrid A. M.

Volltext

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 von Levin, Myron J., Ustianowski, Andrew, De Wit, Stéphane, Launay, Odile, Avila, Miles, Templeton, Alison, Yuan, Yuan, Seegobin, Seth, Ellery, Adam, Levinson, Dennis J., Ambery, Philip, Arends, Rosalinda H., Beavon, Rohini, Dey, Kanika, Garbes, Pedro, Kelly, Elizabeth J., Koh, Gavin C.K.W., Near, Karen A., Padilla, Kelly W., Psachoulia, Konstantina, Sharbaugh, Audrey, Streicher, Katie, Pangalos, Menelas N., Esser, Mark T.

Volltext

Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single‐center study von Schei‐Andersen, Ane J., Hendricks, Linda A. J., Post, Rachel S., Mensenkamp, Arjen R., Schieving, Jolanda, Adank, Muriel A., Duijkers, Floor, Jong, Mirjam, Jongemans, Marjolijn C. J., Hest, Liselotte P., Ierland, Yvette, Kleefstra, Tjitske, Leter, Edward M., Nielsen, Maartje, Schuurs‐Hoeijmakers, Janneke H. M., Hoogerbrugge, Nicoline, Vos, Janet R.

Volltext

Somatic Nonepigenetic Mismatch Repair Gene Aberrations Underly Most Mismatch Repair–Deficient Lynch-Like Tumors von Elze, Lisa, Mensenkamp, Arjen R., Nagtegaal, Iris D., van Zelst-Stams, Wendy A.G., Dommering, Charlotte J., Hoogerbrugge, Nicoline, de Jong, Mirjam M., Bleeker, Fonnet E., Leter, Edward M., Letteboer, Tom G.W., Nielsen, Maartje, van der Post, Rachel S., Wapstra, Brigit, de Voer, Richarda M., Ligtenberg, Marjolijn J.L.

Volltext